Applying the Australian guidelines for the reimbursement of pharmaceuticals

Pharmacoeconomics. 1994 Sep;6(3):196-201. doi: 10.2165/00019053-199406030-00003.
No abstract available

MeSH terms

  • Australia
  • Cost-Benefit Analysis
  • Economics, Pharmaceutical*
  • Guidelines as Topic*
  • Pharmaceutical Services